Table 1.
Transcription datasets with information on gene transcription in PBMC derived from healthy people and patients infected by one of 9 viruses.
| Virus | Dataset | Patient groups | Healthy controls | Platform | Reference |
|---|---|---|---|---|---|
| Cytomegalovirus (CMV) | GSE81246 | Samples from CMV seropositive (n=25) healthy donors and people with symptomatic primary CMV infection (n=11) | Samples from CMV seronegative healthy donors (n=12) | Affymetrix HuGene-2_1-st | (65) |
| Dengue virus (DENV) | GSE18090 | Samples from patients with DHF (n=10) and classical DF (n=8) | Samples (n=8) from febrile patients confirmed to be not infected with DENV | Affymetrix HG-U133 Plus_2 | (52) |
| Epstein–Barr virus (EBV) | GSE45919 | Samples from people during acute EBV infection (n=3) and during latency (n=12) | Samples from people before acquisition of EBV (n=9) | Illumina HumanHT-12 V4.0 | (35) |
| Hepatitis B (HBV) | GSE58208 | Samples from chronic HBV carriers (n=12) | Healthy people (n=5) | Affymetrix HG-U133 Plus_2 | – |
| Hepatitis C (HCV) | GSE40184 | Samples from patients infected with HCV (n=10) | Healthy people (n=6) | Affymetrix HG-U133A | (50) |
| Human immunodeficiency virus (HIV) | GSE77939 | Samples from untreated people living with HIV (n=5) | Healthy people (n=4) | Affymetrix PrimeView | (54) |
| Human T-cell leukemia virus type 1 (HTLV-1) | GSE55851 | Samples from HTLV-1 carriers (n=6) | Healthy people (n=3) | Agilent 026652 4x44K v2 | (51) |
| SARS-CoV-1 | GSE1739 | Samples from patients with SARS (n=10) | Healthy people (n=4) | Affymetrix HG-Focus | (53) |
| SARS-CoV-2 | GSE152418 | Patients with COVID-19: patients in Intensive Care Unit (n=4), patients with severe disease, but not in Intensive Care Unit (n=8), patients with moderate disease (n=4) | Healthy people (n=17) | Illumina NovaSeq 6000 | (49) |
| SARS-CoV-2 | GSE179627 | Samples from patients with COVID-19 (n=13) | Healthy people (n=22) | Illumina NovaSeq 6000 | (55) |